Search this website. You can use fund codes to locate specific funds

Coronavirus

  • 23/09/2020
    The coronavirus and the race for a vaccine
    Katie Frame
    With the coronavirus pandemic set to continue without an effective and widely-available vaccine, all eyes are on the pharmaceutical sector.
  • 21/09/2020
    Credit: Industry Insights
    Ilana Elbim
    With second-quarter earnings wrapped up for US retailers, all eyes are now on the holiday season. How will retailers fare in the second half of the year?
  • 18/09/2020
    Impact investing in the coronavirus era
    Aoifinn Devitt
    Has the coronavirus pandemic resulted in a paradigm shift for responsible investment strategies?
  • 07/09/2020
    Credit: Industry Insights (steel)
    Anna Chong
    Anna Chong, Senior Credit Analyst, presents three key takeaways on the steel sector as we move past Q2 results and into the second half of the year.
  • 02/09/2020
    Impact Opportunities: H1 2020 Report
    Ingrid Kukuljan
    We examine our activity and performance in H1 2020 and explain how three megatrends are shaping our investment thinking.
  • 28/08/2020
    Antimicrobial resistance and the challenge for pharmaceutical companies
    Kimberley Lewis
    A lack of research and development into new antibiotic classes compounds the serious threat that antimicrobial resistance poses to public health.